School of Medicine
Showing 121-140 of 735 Results
-
Chenzhou Hao
Basic Life Research Scientist, Department of Neurobiology
BioMy expertise encompasses drug design, screening, and optimization. Currently, I am collaborating with my team to discover next-generation antiviral drugs targeting potentially pandemic viruses through structure-based drug discovery approaches.
My research interests include scientific visualization and structural biology, and I am eager to contribute to human health as a drug hunter in the future. In addition to my passion for research, I enjoy music, history, and architecture.
https://orcid.org/0000-0001-6803-7270 -
Md Enamul Haque
Biostatistician 3, Ophthalmology Research/Clinical Trials
Current Role at StanfordSr. Research Scientist
-
Pehr Harbury
Associate Professor of Biochemistry
Current Research and Scholarly InterestsScientific breakthroughs often come on the heels of technological advances; advances that expose hidden truths of nature, and provide tools for engineering the world around us. Examples include the telescope (heliocentrism), the Michelson interferometer (relativity) and recombinant DNA (molecular evolution). Our lab explores innovative experimental approaches to problems in molecular biochemistry, focusing on technologies with the potential for broad impact.
-
Antonio Hardan, M.D.
Professor of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsThe neurobiology of autism
Neuroimaging in individuals with autism
Psychopharmacological treatment of children and adults with autism and/or developmental disorders
The neurobiology and innovative interventions of several neurogenic disorders including DiGeorge Syndrome (Velocardiofacial syndrome; 22q11.2 mutations), PTEN mutations, and Phelan McDermid Syndrome (22q13 mutations). -
Josef Hardi
Software Dvlpr 3, Med/BMIR
BioI'm a software engineer with over 15 years of experience building reliable, scalable software systems. I’m especially passionate about software engineering, data modeling, and the emerging potential of agentic large language models (LLMs).
I work at the Stanford Center for Biomedical Informatics Research, where I help develop Protégé and WebProtégé, which are tools used worldwide for creating and managing ontologies. Recently, I contributed to the Human BioMolecular Atlas Program (HuBMAP) project, where I helped build the Human Reference Atlas (HRA) knowledge graph and designed metadata schemas to support a range of assay datasets produced by the consortium.
My core technical strengths are in Java, JavaScript, and Python. I enjoy working at the intersection of software engineering and data to build tools that empower researchers and improve data interoperability. -
Kate Hardy
Clinical Professor, Psychiatry and Behavioral Sciences
BioKate Hardy is a California Licensed Psychologist who has specialized in working with individuals with psychosis for over 20 years in both research and clinical settings. Dr. Hardy received her doctorate in clinical psychology from the University of Liverpool, United Kingdom. She has worked in specialist early psychosis services in both the UK and the US, including UCSF’s Prodrome Assessment Research and Treatment (PART) program, where she completed her post-doctoral fellowship, and as Clinical Director for the Prevention and Recovery from Early Psychosis (PREP) program. Dr. Hardy is the co-director for the INSPIRE clinic at the Department of Psychiatry and Behavioral Health, Stanford University and has significant experience in providing CBTp to individuals with early psychosis, and those at risk of developing psychosis, in both individual and group settings and integration of this clinical intervention to broader systems and staff teams. Dr. Hardy is also involved in the implementation of national strategies to increase dissemination of early psychosis models with the aim of bringing these cutting edge treatments to a broader population and is the co-editor of the book Intervening Early: A team approach.
Dr. Hardy is also the director of INSPIRE training and within this role has led multiple trainings and workshops in CBTp to a wide variety of audiences including community clinicians, psychiatrists, and families, and provides ongoing supervision and consultation in this approach. INSPIRE training offers training in evidence based interventions for psychosis to providers across diverse settings. In 2024 Dr. Hardy became president elect for IEPA: Intervening Early in Mental Health. -
Aubrey Hargrave
Temp - Non-Exempt, Ophthalmology Research/Clinical Trials
BioMy research interests are centered on ocular immunology and neuroinflammation. My long-standing interest in eye research stems from personal experience with eye disease, which has led me to explore vision research and underlies my passion for disease-centric research in order to improve quality of life for patients.
I am fascinated by the immune response and inflammation, in part because of its broad applicability to many human diseases. To this end, I am interested in developing an understanding of the interplay between the immune and nervous systems in the ocular microenvironment and my past research has allowed me to explore this interplay within diverse areas of the eye. As an undergraduate, I conducted research with Dr. Rima Mcleod to study patients with toxoplasmosis, a disease affecting both ocular and neural tissue. We created a patient database and investigated whether genotype influences the inflammatory response to the t.gondii parasite. As a predoctoral student with Dr. Alan Burns, my research focused on ocular inflammation in two cases; first, in acute inflammation following a corneal abrasion and second, in the context of systemic inflammation caused by early metabolic syndrome. I analyzed the immune response in both cases and developed methods to determine the effect on corneal nerves.
During my postdoctoral training with Dr. Alfredo Dubra, I am continuing to build on my previous training in vision science, inflammation, and neurodegeneration by using adaptive optics imaging, in conjunction with standard clinical measurements, to explore potential biomarkers in diseases such as multiple sclerosis, glaucoma, and retinal degeneration. With high-resolution in vivo adaptive optics imaging we are able to monitor changes in retinal tissues at the cellular level over time, as well as to observe minute changes in the retina with treatment during clinical trials. -
Brian A. Hargreaves
Professor of Radiology (Radiological Sciences Laboratory) and, by courtesy, of Electrical Engineering and of Bioengineering
Current Research and Scholarly InterestsI am interested in magnetic resonance imaging (MRI) applications and augmented reality applications in medicine. These include abdominal, breast and musculoskeletal imaging, which require development of faster, quantitative, and more efficient MRI methods that provide improved diagnostic contrast compared with current methods. My work includes novel excitation schemes, efficient imaging methods and reconstruction tools and augmented reality in medicine.
